Tobii will be the exclusive source of ControlRad’s eye-tracker interface for its solution that provides up to 75% radiation reduction technology without reducing image quality or impacting provider workflow
PHILADELPHIA (PRWEB) October 30, 2018
ControlRad, Inc., a medical technology company focused on dramatically reducing unnecessary radiation exposure to patients and physicians during fluoroscopic procedures, announced today a partnership with Stockholm-based Tobii AB, the world leader in eye-tracking technology. Tobii will be the exclusive source of ControlRad’s eye-tracker interface for its solution that provides up to 75% radiation reduction technology without reducing image quality or impacting provider workflow.
Eye-tracking technology is used in a variety of commercial, scientific, research, and consumer applications across a wide range of devices and platforms, including in assistive technology hardware and software integrations that help those with communication and mobility challenges. This will be the first and only application of Tobii’s eye tracking solution in the medical imaging radiation reduction field.
“ControlRad is excited to partner with Tobii, the leader in eye-tracking technology,” said Guillaume Bailliard, President and CEO of ControlRad. “We’ve already demonstrated, including in a peer-reviewed study, that we can reduce radiation exposure to both patients and the medical staff by up to 75% using an eye-tracker. This partnership allows us to integrate the state-of-the-art Tobii eye-trackers to maximize these results. Specifically, the eye-tracking technology allows the operator to seamlessly control the X-ray beam optimizing image quality to a clinically-relevant region-of-interest while delivering appropriate detail in the surrounding image.”
ControlRad is a privately-held medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided interventional procedures (FGIP) for patients and healthcare professionals. These products are designed to improve safety without compromising image quality or workflow. This is accomplished with an integrated set of proprietary components which optimize the X-ray beam to deliver optimal image quality in the clinically-relevant region while maintaining appropriate resolution in the periphery. ControlRad is headquartered in Philadelphia and has engineering development facilities in Kfar Saba, Israel. For more information, visit http://www.controlrad.com.
About Tobii Group
Tobii is the global leader in eye tracking. Tobii’s vision is a world where all technology works in harmony with natural human behavior. Tobii operates through three business units: Tobii Dynavox makes specially designed computers that are controlled by eye movement or touch screens for use by people with special needs due to spinal cord injuries, CP, ALS or other medical conditions. Tobii Pro develops and sells eye-tracking equipment and services used today by more than 3,000 companies and 2,000 research institutions, including all of the world’s 50 highest ranked universities. Tobii Tech further develops Tobii’s technology for new volume markets, such as computer games, personal computers, virtual reality and smartphones. Tobii is headquartered in Sweden and is listed on Nasdaq Stockholm (TOBII). The group has about 1,000 employees. For more information, visit http://www.tobii.com.